CIK 0001860742 · Large accelerated filer
Bausch & Lomb Corp
Sign in to watch- Ticker
- BLCO
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 908-541-5456
- Business address
- 520 APPLEWOOD CRESCENT, VAUGHAN, Ontario, Canada, L4K 4B4
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,294,067
- in 1 filing
Net −$2,294,067. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-01 | ROBERTSON RUSSEL C Director | Grant or award | +2,210 | $11.59 | $26K | 44,576 |
| 2025-05-01 | Paulson John Director | Grant or award | +1,887 | $11.59 | $22K | 49,627 |
| 2025-04-24 | Stewart Andrew J. See remarks | Shares withheld for taxes | −3,954 | $13.89 | $55K | 62,930 |
| 2025-04-24 | Bailey A Robert D EVP & Chief Legal Officer | Shares withheld for taxes | −9,781 | $13.89 | $136K | 170,576 |
| 2025-02-28 | Bonnefoy Luc President,Surgical | Shares withheld for taxes | −1,110 | $16.00 | $18K | 77,380 |
| 2025-02-28 | Bonnefoy Luc President,Surgical | Shares withheld for taxes | −3,029 | $16.00 | $48K | 74,351 |
| 2025-02-26 | Munsch Frederick SVP, Controller and CAO | Grant or award | +18,581 | 71,294 | ||
| 2025-02-26 | Bonnefoy Luc President,Surgical | Grant or award | +23,423 | 78,490 | ||
| 2025-02-26 | Bonnefoy Luc President,Surgical | Grant or award · Non-Qualified Stock Options (right to purchase) | +55,793 | 55,793 | ||
| 2025-02-26 | Stewart Andrew J. See remarks | Grant or award | +23,423 | 66,884 | ||
| 2025-02-26 | Stewart Andrew J. See remarks | Grant or award · Non-Qualified Stock Options (right to purchase) | +55,793 | 55,793 | ||
| 2025-02-26 | Hashad Yehia EVP of R&D and CMO | Grant or award | +25,225 | 119,580 | ||
| 2025-02-26 | Hashad Yehia EVP of R&D and CMO | Grant or award · Non-Qualified Stock Options (right to purchase) | +60,085 | 60,085 | ||
| 2025-02-26 | Bailey A Robert D EVP & Chief Legal Officer | Grant or award | +40,540 | 180,357 | ||
| 2025-02-26 | Bailey A Robert D EVP & Chief Legal Officer | Grant or award · Non-Qualified Stock Options (right to purchase) | +96,566 | $15.86 | $1.5M | 96,566 |
| 2025-02-26 | Eldessouky Sam EVP and CFO | Grant or award | +59,459 | 282,295 | ||
| 2025-02-26 | Eldessouky Sam EVP and CFO | Grant or award · Non-Qualified Stock Options (right to purchase) | +141,630 | 141,630 | ||
| 2025-02-26 | SAUNDERS BRENT L CEO and Chairman of the Board | Grant or award | +168,168 | 697,156 | ||
| 2025-02-26 | SAUNDERS BRENT L CEO and Chairman of the Board | Grant or award · Non-Qualified Stock Options (right to purchase) | +600,858 | 600,858 | ||
| 2024-12-23 | Stewart Andrew J. See remarks | Shares withheld for taxes | −2,524 | $17.83 | $45K | 43,461 |
Page 7 of 14 · 269 trades